More than 50% of human tumours carry mutations in TP53, so strategies to restore the activity of this tumour suppressor in cancer cells are being actively investigated by drug companies. A team of researchers in Sweden and Russia now report the discovery of a compound that reactivates p53 function and induces apoptosis in human cancer cells.
CITATION STYLE
Novak, K. (2002). p53 restoration. Nature Reviews Cancer, 2(3), 159–159. https://doi.org/10.1038/nrc771
Mendeley helps you to discover research relevant for your work.